BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Endothelial cell, Amniocentesis, Doxorubicin, rs4950928, FXYD4, Hepatitis)
Bookmark Forward

QuickView for POR (gene)


Body Atlas

Most Correlated Tissues

  1. Liver
  2. Adrenal gland cortex
  3. Thyroid gland
  4. Adrenal gland
  5. Fetal liver
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Congenital adrenal hyperplasia
  2. Pseudohermaphroditism
  3. Craniosynostosis syndrome
  4. Effects of heat
  5. Disease due to Adenovirus
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Chlormadinone Acetate
  2. tetrabrominated diphenyl ether 47
  3. Miconazole
  4. Safrole
  5. Phenobarbital
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. SHC2
  2. COPS5
  3. UBD
  4. GJB1
  5. RBM38
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Clinical and genetic analysis of cytochrome P450 oxidoreductase (POR) deficiency in a female and the…
  2. POR polymorphisms are associated with 21 hydroxylase deficiency.
  3. The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a…
  4. Assessing POR and CYB5R1 oxidoreductase-mediated oxidative rupture of PUFA in liposomes.
  5. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Effect of Testosterone Pretreatment in POR
  2. ¡Salud! Por la Vida (SPLV) A Colorectal Screening Promotion Program
  3. Second Step Protocol in Poor Ovarian Responder (POR)
  4. Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnos…
  5. Unidas Por Vida y Salud: Increasing Breast and Cervical Cancer Screening in El Paso
Explore Clinical Trials Results
  • Copyright © 2022 Illumina Inc. All rights reserved.